Executive order for price controls will harm innovation and patients

President Donald Trump just signed a new executive order to reform our healthcare system. While his desire to lower costs for patients is appropriate, the proposed changes would do more harm than good.

The new “most-favored-nation” executive order would tie Medicare payments for certain medicines to the lowest price paid in other foreign nations. While this would result in some modest and short-term government savings, it would also have disastrous consequences for American patients and severely restrict the discovery of new life-improving and life-saving drugs that target ailments like Alzhei...